An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03001882 · COMPLETED
Trial details
- NCT number
- NCT03001882
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-29
- Primary completion
- 2022-02-17
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.